Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 13 October 2006. doi:10.1136/ard.2006.054734
Annals of the Rheumatic Diseases 2007;66:458-463
Copyright © 2007 BMJ Publishing Group Ltd & European League Against Rheumatism

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ard.2006.054734v1
ard.2006.054734v2
ard.2006.054734v3
ard.2006.054734v4
66/4/458    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Senolt, L
Right arrow Articles by Haluzík, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Senolt, L
Right arrow Articles by Haluzík, M

EXTENDED REPORT

Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum

L Senolt 1, D Housa 2, Z Vernerová 2, T Jirásek 2, R Svobodová 1, D Veigl 3, K Anderlová 4, U Müller-Ladner 5, K Pavelka 1, M Haluzík 4

1 Institute of Rheumatology, 1st Medical Faculty, Charles University, Prague, Czech Republic
2 Department of Pathology, 1st Medical Faculty, Charles University, Prague, Czech Republic
3 Clinic of Orthopaedic Surgery, 1st Medical Faculty, Charles University, Prague, Czech Republic
4 3rd Department of Medicine, 1st Medical Faculty, Charles University, Prague, Czech Republic
5 University Hospital Giessen, Department of Internal Medicine and Rheumatology, Division of Rheumatology and Clinical Immunology, Giessen, Germany

Correspondence to:
Correspondence to:
Dr L Senolt
Institute of Rheumatology, Na Slupi 4, 12850 Prague 2, Czech Republic; seno{at}revma.cz

Background: Resistin is a newly identified adipocytokine which has demonstrated links between obesity and insulin resistance in rodents. In humans, proinflammatory properties of resistin are superior to its insulin resistance-inducing effects.

Objectives: To assess resistin expression in synovial tissues, serum and synovial fluid from patients with rheumatoid arthritis, osteoarthritis and spondylarthropathies (SpA), and to study its relationship with inflammatory status and rheumatoid arthritis disease activity.

Methods: Resistin expression and localisation in synovial tissue was determined by immunohistochemistry and confocal microscopy. Serum and synovial fluid resistin, leptin, interleukin (IL)1ß, IL6, IL8, tumour necrosis factor {alpha}, and monocyte chemoattractant protein-1 levels were measured. The clinical activity of patients with rheumatoid arthritis was assessed according to the 28 joint count Disease Activity Score (DAS28).

Results: Resistin was detected in the synovium in both rheumatoid arthritis and osteoarthritis. Staining in the sublining layer was more intensive in patients with rheumatoid arthritis compared with those with osteoarthritis. In rheumatoid arthritis, macrophages (CD68), B lymphocytes (CD20) and plasma cells (CD138) but not T lymphocytes (CD3) showed colocalisation with resistin. Synovial fluid resistin was higher in patients with rheumatoid arthritis than in those with SpA or osteoarthritis (both p<0.001). In patients with rheumatoid arthritis and SpA, serum resistin levels were higher than those with osteoarthritis (p<0.01). Increased serum resistin in patients with rheumatoid arthritis correlated with both CRP (r = 0.53, p<0.02), and DAS28 (r = 0.44, p<0.05), but not with selected (adipo) cytokines.

Conclusion: The upregulated resistin at local sites of inflammation and the link between serum resistin, inflammation and disease activity suggest a role for resistin in the pathogenesis of rheumatoid arthritis.


Abbreviations: DAS28, Disease Activity Score 28; DMARDs, disease-modifying antirheumatic drugs; SpA, spondylarthropathy; TNF, tumour necrosis factor




This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
H. Forsblad d'Elia, R. Pullerits, H. Carlsten, and M. Bokarewa
Resistin in serum is associated with higher levels of IL-1Ra in post-menopausal women with rheumatoid arthritis
Rheumatology, July 1, 2008; 47(7): 1082 - 1087.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
M. Qatanani and M. A. Lazar
Mechanisms of obesity-associated insulin resistance: many choices on the menu
Genes & Dev., June 15, 2007; 21(12): 1443 - 1455.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 BMJ Publishing Group Ltd & European League Against Rheumatism